Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-53287
Gridelli, C; Stahel, R; Besse, B; Ciardiello, F; Felip, E; Gasparini, S; Graziano, P; Rossi, A; de Marinis, F (2011). Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting. Lung Cancer, 74(3):544-548.
PDF - Registered users only
The European Medicine Agency grants marketing of drugs in all Europe, regulatory agency of each country can register the drug, but can also deny public reimbursement thus restricting the options of the oncologist. The European Oncology Associations should join to their effort to achieve a uniform access to the cancer therapy for all patients in Europe.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology|
|DDC:||610 Medicine & health|
|Deposited On:||12 Jan 2012 15:26|
|Last Modified:||27 Nov 2013 19:36|
|Citations:||Web of Science®. Times cited: 1|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page